Study to Evaluate Optimized Retreatment and Prolonged Therapy With Bortezomib
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to describe the effect of optimized retreatment with
bortezomib in combination with dexamethasone followed by prolonged therapy with bortezomib,
versus standard retreatment with bortezomib in combination with dexamethasone on progression
free survival (PFS).